top of page

Cannabis-derived
APIs

Manufactured under certificates sukls105303/2023, sukls297906/2024

Dronabinol

(–)-trans-delta-9-Tetrahydrocannabinol

Complies with DAC/NRF 2021/2, D – 100

 

12 months retest days for ICH Zone II

 

Packaging: 1000 ml brown glass bottle

 

MOQ 1000 g

CANNABIDIOL

(–)-trans-Cannabidiol

Complies with Ph. Eur. 07/2024:3151

24 months retest date for ICH Zone II and IVb

 

Flexible packaging options in HDPE/ALU: 1000 g, 100 g, 50 g, 10 g, 1 g

MOQ 1000 g

Refined Cannabis Extract

Cannabis Extractum Raffinatum

~75 % cannabinoid content

THC-dominant

 

CBD-dominant

 

Balanced

 

Toll manufactured

 

Packaging: 1000 ml brown glass bottle

 

MOQ 500 g

Adjusted Cannabis Extract

Cannabis Extractum Normatum

1 – 25% THC

Complies with DAB 2020 Eingestellter

Cannabisextrakt

 

T18 interim stability available for ICH Zone II

 

Toll manufactured

 

Packaging: 1000 ml brown glass bottle

 

MOQ 10 L

Certification

sukls105303/2023

sukls297906/2024

CB21 Pharma, has successfully extended its EU Good Manufacturing Practice (GMP) certification under certificates # sukls105303/2023 and sukls297906/2024. This achievement allows CB21 Pharma to continue manufacturing Active Pharmaceutical Ingredients (APIs), such as Cannabidiol (CBD), from initial extraction to the production of full spectrum refined and standardized extracts from medicinal cannabis, marketed as Cannabis Extractum Raffinatum et Normatum. The extended EU GMP certificate certifies the complete production flow from extraction, decarboxylation, purification, crystallization, and packaging of cannabis-derived APIs.

Our in-house analytical procedures are also EU GMP-certified.

 

 

Narcotic license 39/2023

This narcotic license issued by the Ministry of Health of the Czech Republic allows CB21 Pharma to handle all cannabis related materials.

Contract processing

Our EU GMP manufacturing certification and the Narcotic license issued by the Czech Ministry of Health allow us to process your high THC or high CBD GACP/GMP cannabis herba (flos) into a variety of bulk extracts and isolates.

This option might come in handy to medicinal cannabis producers or distributors with stock nearing the end of its shelf life. By processing the nearly expiring material into an extract, you add value to it and give it a second chance for sale.

Services

Oily Solutions

On special request, we can supply oily solutions of cannabidiol as well as standardized bulk or private-label solutions according to accepted monographs.

Our oily solutions comply with the following monographs: NRF 22.8., NRF 22.10., DAB 2020.

Logo CB21 Pharma

Invoicing details

CB21 Pharma s.r.o.

Purkyňova 648/125
612 00 Brno

​Czech Republic

​​Company ID: 07563094

 

VAT No.: CZ07563094

Company registered in the Commercial Register kept by the Regional Court in Brno, file number C108810

Office address

CB21 Pharma s.r.o.

Přívozní 1054/2

170 00 Prague 7

Czech Republic

© 2024 by CB21 Pharma s.r.o.

  • Facebook
  • Instagram
  • LinkedIn
bottom of page